相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Limiting the power of p53 through the ubiquitin proteasome pathway
Vinod Pant et al.
GENES & DEVELOPMENT (2014)
DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells
Yegor Smurnyy et al.
NATURE CHEMICAL BIOLOGY (2014)
DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets
Corynn Kasap et al.
NATURE CHEMICAL BIOLOGY (2014)
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo Kian Hoe et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays
Camilo Guzman et al.
PLOS ONE (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38
A. Weilbacher et al.
CELL DEATH & DISEASE (2014)
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
Joel P. Charles et al.
NATURE COMMUNICATIONS (2014)
Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks
Changxian Shen et al.
CANCER RESEARCH (2013)
In vitro FANCD2 monoubiquitination by HHR6 and hRad18
Anna Pickering et al.
CELL CYCLE (2013)
Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro
Mikhail Burmakin et al.
CLINICAL CANCER RESEARCH (2013)
mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells
F. Guo et al.
LEUKEMIA (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Unravelling cancer stem cell potential
Benjamin Beck et al.
NATURE REVIEWS CANCER (2013)
A simple statistical test to infer the causality of target/phenotype correlation from small molecule phenotypic screens
Xin Wei et al.
BIOINFORMATICS (2012)
Chk2 mediates RITA-induced apoptosis
J. de Lange et al.
CELL DEATH AND DIFFERENTIATION (2012)
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway
Hyungjin Kim et al.
GENES & DEVELOPMENT (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI
Stacy A. Williams et al.
BLOOD (2011)
FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons
Lisa A. Kachnic et al.
CANCER LETTERS (2011)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
M. Michaelis et al.
CELL DEATH & DISEASE (2011)
AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity
Christine M. Chresta et al.
CANCER RESEARCH (2010)
Rescue of the apoptotic-inducing function of mutant p53 by small molecule RITA
Carolyn Y. Zhao et al.
CELL CYCLE (2010)
Rad18-mediated Translesion Synthesis of Bulky DNA Adducts Is Coupled to Activation of the Fanconi Anemia DNA Repair Pathway
Ihn Young Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
DNA Binding Cooperativity of p53 Modulates the Decision between Cell-Cycle Arrest and Apoptosis
Katharina Schlereth et al.
MOLECULAR CELL (2010)
Stage-specific sensitivity to p53 restoration during lung cancer progression
David M. Feldser et al.
NATURE (2010)
Convergence of Rad6/Rad18 and Fanconi Anemia Tumor Suppressor Pathways upon DNA Damage
Hwan Ki Park et al.
PLOS ONE (2010)
Ablation of Key Oncogenic Pathways by RITA-Reactivated p53 Is Required for Efficient Apoptosis
Vera V. Grinkevich et al.
CANCER CELL (2009)
MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53
Martin Enge et al.
CANCER CELL (2009)
Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
Martin Michaelis et al.
CANCER RESEARCH (2009)
3′UTR mediated regulation of the cyclin D1 proto-oncogene
Anagha Deshpande et al.
CELL CYCLE (2009)
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
Giulia Bertolini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways
Jun Zhang et al.
CELL CYCLE (2008)
HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function
L. M. S. Lau et al.
ONCOGENE (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Restoration of p53 function leads to tumour regression in vivo
Andrea Ventura et al.
NATURE (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Modeling the therapeutic efficacy of p53 restoration in tumors
Carla P. Martins et al.
CELL (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro
M Krajewski et al.
NATURE MEDICINE (2005)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks
LJ Niedernhofer et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors
N Issaeva et al.
NATURE MEDICINE (2004)
分享论文
